KL and neoplasm: Consistent with the decreased levels of HBP metabolites in KL co-mutant cells, FR054 reduced O-GlcNAcylation (Figure 4D) and tumor-associated glycan structures (Figure 4E–K) only in KL co-mutant cells and not in K mutant cells.